Previous 10 | Next 10 |
Top Penny Stocks For Your List Right Now Penny stocks are some of the highest risk investments you can make. But their innate ability to record explosive gains is undeniable. What are penny stocks ? All we’re talking about here are stocks under $5. According to the Securities...
SCOTTSDALE, Ariz. and NEW YORK, April 05, 2021 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical”), a partner company of Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), today announced that it has entered into an agreement with East West Bank ...
Are These The Top Biotech Penny Stocks to Buy in April? The pandemic has shined a large spotlight on biotech penny stocks over the past twelve months. Every time a company announced a new treatment or vaccine for Covid, traders quickly jumped to buy the trend. As a result, many breakout...
Journey Medical Corporation, a subsidiary of Fortress Biotech ([[FBIO]] +8.6%) has agreed to acquire Qbrexza (glycopyrronium) in the U.S. from Dermira, a wholly-owned subsidiary of Eli Lilly and Company ([[LLY]] -0.8%).The financial terms of the transaction which is expected t...
SCOTTSDALE, Ariz. and NEW YORK, April 01, 2021 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical”), a partner company of Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), today announced that it has entered into a definitive agreement to acquire...
Fortress Biotech (FBIO): FY Non-GAAP EPS of -$0.40 beats by $0.34; GAAP EPS of -$0.65 beats by $0.08.Revenue of $45.6M (+24.5% Y/Y) beats by $1.54M.Shares +4%.Press Release For further details see: Fortress Biotech EPS beats by $0.34, beats on revenue
Revenue from marketed dermatology products increased 28% for full-year 2020 compared to 2019 Our partner company, Cyprium Therapeutics, and Sentynl Therapeutics, a wholly-owned subsidiary of the Zydus Group, signed a Development and Asset Purchase Agreement for CUTX-101 fo...
3 Robinhood Penny Stocks to Watch If You’ve Been Watching Biotech As far as biotech penny stocks go, the choices are almost limitless. But, just because there are many to choose from does not mean that they all have potential. Rather, it’s important to consider a few d...
The following slide deck was published by Fortress Biotech, Inc. in conjunction with this event. For further details see: Fortress Biotech (FBIO) Investor Presentation - Slideshow
NEW YORK, March 24, 2021 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumo...
News, Short Squeeze, Breakout and More Instantly...
Fortress Biotech Inc. Company Name:
FBIO Stock Symbol:
NASDAQ Market:
Fortress Biotech Inc. Website:
MIAMI, July 25, 2024 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”, or the “Company”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equity ...
WALTHAM, Mass., July 25, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced that the U.S. Food and Drug Administration (“FDA”) has accepted for review Check...
Collaboration explores the potential synergistic effects of Checkpoint’s anti-PD-L1, cosibelimab, in combination with the autologous T cell therapy, Immuncell-LC YONGIN, South Korea and WALTHAM, Mass., July 15, 2024 (GLOBE NEWSWIRE) -- GC Cell (KRX: 144510.KS) and Checkpoin...